Fibronectin binding is considered to be an important virulence factor in streptococcal infections. Adhesion of the oral bacterium Streptococcus gordonii to immobilized forms of fibronectin is mediated, in part, by a high molecular mass wall-anchored protein designated CshA. In this study, a second fibronectin-binding protein of S. gordonii is described that has been designated as FbpA (627 kDa). This protein, which is encoded by a gene located immediately downstream of the cshA gene, shows 85 and 81 % identity to the fibronectin-binding proteins PavA, of Streptococcus pneumoniae, and FBP54, of Streptococcus pyogenes, respectively. Purified recombinant FbpA bound to immobilized human fibronectin in a dose-dependant manner, and isogenic mutants in which the fbpA gene was inactivated were impaired in their binding to fibronectin. This effect was apparent only for cells in the exponential phase of growth, and was associated with reduced surface hydrophobicity and the surface expression of CshA. Cells in the stationary phase of growth were unaffected in their ability to bind to fibronectin. By utilizing gene promoter fusions with cat (encoding chloramphenicol O-acetyltransferase), it was demonstrated that cshA expression was downregulated during the exponential phase of growth in the fbpA mutant. Expression of fbpA, but not cshA, was sensitive to atmospheric O 2 levels, and was found to be up-regulated in the presence of elevated O 2 levels. The results suggest that FbpA plays a regulatory role in the modulation of CshA expression and, thus, affects the adhesion of S. gordonii to fibronectin.
INTRODUCTION

Mitis group streptococci [including Streptococcus gordonii, Streptococcus mitis, Streptococcus oralis and
Streptococcus sanguis (sanguinis) ; Kawamura et al., 1995] are found at most sites within the human oral cavity and are numerically abundant in dental plaque (Frandsen et al., 1991) . Colonization and persistence of streptococci in the oral cavity depends, at least in part, on their ability to adhere to oral surfaces, including the salivary pellicle on teeth, to other oral bacteria in plaque and to host epithelial cells (Whittaker et al., 1996 ;  ... 
Abbreviation : CAT, chloramphenicol O-acetyltransferase.
The GenBank accession number for the sequence reported in this paper is X65164. Jenkinson & Lamont, 1997) . Mitis group streptococci are also frequently isolated as the causative agents of infective endocarditis (Douglas et al., 1993 ; Dyson et al., 1999) . The ability of these bacteria to aggregate platelets and to adhere to endothelial cells, to platelet-fibrin thrombi and to extracellular matrix components (e.g. fibronectin) at sites of native heart-valve damage are thought to contribute to their disease potential (Lowrance et al., 1990 ; Baddour, 1994 ; Herzberg, 1996) .
Fibronectin is a dimeric glycoprotein (approx. 440 kDa) that is present in a soluble form in plasma and extracellular fluids ; it is also present in a fibrillar form on cell surfaces. Both the soluble and cellular forms of fibronectin may be incorporated into the extracellular tissue matrix (reviewed by Romberger, 1997) . While fibronectin has critical roles in eukaryotic cellular processes, such as adhesion, migration and differentiation, it is also a substrate for the attachment of bacteria.
The binding of pathogenic Streptococcus pyogenes and Staphylococcus aureus to epithelial cells via fibronectin facilitates their internalization (Joh et al., 1999) and systemic spread within the host. The best-characterized fibronectin-binding proteins from streptococci and staphylococci share a similar mosaic architecture (Joh et al., 1994 (Joh et al., , 1999 . These cellsurface proteins possess an N-terminal signal peptide for sec-dependent secretion and an LPXTG C-terminal motif for covalent anchorage to cell-wall peptidoglycan (Navarre & Schneewind, 1999) . A consensus sequence [ED(T\S)(9 or 10 X)GG(3 or 4 X)(I\V)DF, where X is any amino acid] that occurs in multiple copies within the carboxy-terminal amino acid repeat regions of these proteins is important for their fibronectin-binding activities (Joh et al., 1994 (Joh et al., , 1999 . Streptococci also express several atypical fibronectin-binding proteins. These proteins do not contain conventional secretion, anchorage or fibronectin-binding sequences ; examples include FBP54 (Courtney et al., 1994) and SDH (Pancholi & Fischetti, 1992) in Streptococcus pyogenes, and PavA in Streptococcus pneumoniae (Holmes et al., 2001) . Fibronectin is present on oral epithelial cells and in submandibular\sublingual and parotid saliva, and is deposited within the acquired pellicle that coats the tooth surface (Zetter et al., 1979 ; Babu et al., 1983 ; Babu & Dabbous, 1986 ; Ericson & Tynelius-Bratthall, 1986) . A range of oral streptococci have been shown to bind fibronectin (Babu et al., 1983 ; Babu & Dabbous, 1986 ; Ericson & Tynelius-Bratthall, 1986 ; van der Flier et al., 1995 ; Willcox et al., 1995) but, in general, little is known about the adhesins involved in this binding. Most molecular studies have been carried out on S. gordonii, which binds to conformationally specific determinants of immobilized human fibronectin that are not presented by soluble plasma fibronectin (Lowrance et al., 1988) . Fibronectin binding is mediated by a 259 kDa cell-wall-anchored protein, CshA, which also confers cell-surface hydrophobicity and co-aggregation properties with Actinomyces spp., Candida albicans and S. oralis (Holmes et al., 1996 ; McNab et al., 1996) . CshA is the structural and functional component of the 60 nm long peritrichous fibrils that are present on the S. gordonii cell surface (McNab et al., 1999) . Isogenic cshA mutants of S. gordonii show approximately 50 % reduction in their ability to bind to immobilized human fibronectin when compared to the wild-type (McNab et al., 1996) , and are unable to colonize the murine oral cavity. There are no significant amino acid sequence similarities between CshA and other wall-anchored staphylococcal and streptococcal fibronectin-binding proteins, perhaps reflecting the binding specificity of CshA for immobilized fibronectin. Sequencing upstream and downstream of the cshA locus in S. gordonii revealed a gene, downstream of cshA and convergently transcribed, encoding a polypeptide with high sequence similarity to FBP54, a fibronectin-binding protein in S. pyogenes (Courtney et al., 1994) . This raised the possibility that there was a ' host-association' locus on the S. gordonii chromosome that encoded a second adhesin (designated FbpA) mediating attachment of S. gordonii to fibronectin. In this paper, we demonstrate that while FbpA binds to immobilized human fibronectin, the effects observed on the ability of S. gordonii to bind fibronectin upon inactivation of the fbpA gene probably arise through modulation of the expression of CshA.
METHODS
Bacterial strains and media. The bacterial strains and plasmids used in this study are listed in Table 1 . Streptococci were grown at 37 mC on BHY agar containing 37 g brain heart infusion l − " (Difco), 5 g yeast extract l − " and 1n5% (w\v) agar. Liquid cultures were grown without shaking in screw-cap tubes or in bottles at 37 mC in BHY medium or in TY-glucose medium (Jenkinson et al., 1993) . For aeration experiments, cultures (20 ml) were grown in flasks (200 ml) with gyratory shaking (200 r.p.m.) . Anaerobic cultures were grown without shaking under 80 % N # , 10% CO # and 10 % H # , in an anaerobic cabinet. Escherichia coli strains were grown aerobically at 37 mC in LB (Sambrook et al., 1989) . The concentrations of the antibiotics used for selection were as follows : 100 µg ampicillin ml − " (E. coli); 50 µg kanamycin ml − " (E. coli); 12n5 µg tetracycline ml -" (E. coli) or 5 µg tetracycline ml − " (S. gordonii); 50 µg erythromycin ml − " (E. coli) or 1 µg erythromycin ml − " (S. gordonii) ; 100 µg spectinomycin ml − " (E. coli and S. gordonii); 5 µg chloramphenicol ml − " (S. gordonii). DNA and RNA manipulations. Routine molecular biology techniques were performed as specified by Sambrook et al. (1989) . Plasmid DNA was isolated from E. coli using Concert Minipreps (Gibco Life Technologies) and PCR products were purified by using the Qiaquick Kit (Qiagen). Chromosomal DNA was isolated from S. gordonii as described previously (Jenkinson, 1987) . S. gordonii cells were transformed with DNA according to the method of Haisman & Jenkinson (1991) . Restriction and modifying enzymes (New England Biolabs) were used under the conditions recommended by the manufacturer. DNA sequencing was performed with cloningvector-derived primers (M13 forward, M13 reverse, T7 or SP6) or custom-synthesized oligonucleotides (MWG-BIO-TECH), using an Applied Biosystems model 373A automated DNA sequencer, or manually using Sequenase (United States Biochemical). Sequence data were analysed with  (Lynnon Biosoft), Genejockey or DNA Strider. The  algorithm (Altschul et al., 1990) was utilized for database searches. DNA sequence information 3h to the TGA stop codon of cshA was obtained in two stages, as outlined below. Plasmid pPH1704 contained a 2n2 kb S. gordonii DNA fragment, 1n5 kb of which has been shown to encode the carboxy terminus of CshA (McNab & Jenkinson, 1992) . The sequence of the remaining 0n7 kb of the S. gordonii DNA fragment was determined and used to design primers for inverse PCR amplification of flanking DNA (McNab et al., 1994) . Briefly, S. gordonii DL1 genomic DNA was digested with SspI, selfligated at 3n5 ng µl − " and then used as a template for PCR (Expand High Fidelity System ; Boehringer Mannheim) with the primers CTERM (5h-TTATACAGGACAGAAAACCC3h ; complementary to nucleotides 8298-8317, cshA locus ; GenBank accession no. X65164) and IFBPA (5h-GCTCCACC-TGATCTTGGTCG-3h ; complementary to nucleotides 8907-8926) (30 cycles, 60 mC annealing temperature, 3 min extension at 72 mC). The PCR product (3n63 kb) was purified and subcloned into pUC19 for sequencing. 
Hanahan (1985) M15 ( Total RNA was prepared from S. gordonii cells as described previously (McNab & Jenkinson, 1998) . RNA samples (10 µg lane − ") were prepared for electrophoresis and separated on 1n2% (w\v) agarose gels. The RNA was then transferred to a nylon membrane, as described by Kroczek & Siebert (1990) . Hybridization of the blots with a $#P-labelled fbpA gene fragment was performed as described by Church & Gilbert (1984) , with solutions containing 8 % (w\v) dextran sulphate. The blots were washed three times each for 20 min with 2iSSC containing 0n1 % SDS at 65 mC ; the radiolabelled bands were detected by autoradiography.
Preparation of antiserum to FbpA. Antibodies were raised against FbpA that had been produced initially as a glutathione S-transferase fusion protein. Primers HJ30 (5h-ACGGATCC-GCAGCAATCGCAAAAGCC-3h ; BamHI site shown in bold type ; complementary to nucleotides 9765-9794) and HJ31 (5h-TCAATCATGTCGACTTGGACAAG-3h ; SalI site shown in bold type ; complementary to nucleotides 8366-8388) were used in PCR to amplify an internal fragment of fbpA encoding amino acid residues 39-511. The PCR product was digested with a combination of BamHI and SalI and cloned into pGEX-5X-3 (Amersham Pharmacia Biotech) that had been similarly digested. FbpA from E. coli lysates was purified on a glutathione-Sepharose column, as described by McNab et al. (1996) . Antibodies against recombinant FbpA were raised in New Zealand White rabbits by intramuscular injection of 80 µg of protein ; booster injections (30 µg each) were administered after 2 and 3 months.
Purification of the recombinant FbpA polypeptide. To produce N-terminal His-tagged FbpA for use in proteinbinding assays, the entire coding region of FbpA was amplified by PCR from S. gordonii DL1 genomic DNA using the primers HisF1 (5h-TTCGACGGATCCTTTTTACATCAC-3h ; BamHI site shown in bold type) and HisR1 (5h-AAGAGAG-AGTCGACCCTATTTATA-3h ; SalI site shown in bold type). The PCR product was digested with BamHI and SalI and ligated into pQE30 that had been similarly digested. The plasmid construct was then transformed into E. coli M15. Expression of the His-tagged FbpA protein was induced by the addition of 0n01 mM IPTG to cultures in the exponential phase of growth. After a further 4 h incubation at 30 mC, cells were harvested by centrifugation, suspended in lysis buffer [0n05 M NaH # PO % , 250 mM NaCl, pH 8n0, containing 1 mM PMSF and 0n1 % (v\v) protease inhibitor cocktail (Sigma) for use with bacterial cell extracts] and then lysed by sonication. Proteins were extracted from the lysates with 8 M urea, and FbpA was purified on a nickel-NTA resin column, according to the manufacturer's guidelines. Eluted proteins were dialysed extensively against de-ionized water at 4 mC.
Construction of the fbpA mutant strain. A portion of the fbpA gene (encoding amino acids 1-175 of FbpA) was amplified by PCR using primers FLPID3 (5h-GTCTTTCTA-GAGATTTTTTTTAC-3h ; XbaI site shown in bold type) and FLPID4 (5h-CAGTGAAAGGATCCAGACTG-3h ; BamHI site shown in bold type). The 525 bp product was purified, digested with a combination of XbaI and BamHI, and then ligated with the integration vector pSF143 (Tao et al., 1992) , which had been similarly digested. The resultant plasmid, pSFBP1, was transformed into competent S. gordonii DL1 cells with selection for tetracycline resistance to generate recombinant strain UB1060. Southern-blot analysis (using the ECL DNA Labelling and Detection System ; Amersham Life Sciences) was performed to confirm that the plasmid had been integrated into the S. gordonii chromosome at the predicted locus.
S. gordonii strain OB507 carries a chromosomal cshA promoter-cat (p-cshA-cat) fusion (McNab & Jenkinson, 1998) . To generate a fbpA knockout mutant in this reporter strain, the PCR product amplified using primers FLPID3 and FLPID4 was digested with XbaI and BamHI, and ligated with integration vector pFW5 (Podbielski et al., 1996) , which had been similarly digested. The resulting plasmid, pFWFLP1, was inserted onto the S. gordonii OB507 chromosome by trans-formation and selection for tetracycline and spectinomycin resistance, to generate strain UB1245. Construction of the strain carrying p-flpA-cat. The fbpA promoter region was amplified by PCR using primers PROMF (5h-TTCTTCTAGATTTATCAGTAAATTACC-3h ; XbaI site shown in bold type ; complementary to nucleotides 10 185-10 211, cshA locus) and FUSION2 (5h-GCCTCCGGA-TTTCGAGCTCCTTGAAAGTTACTATAGAA-3h ; complementary to nucleotides 9908-9928). To enable ligation-PCR, FUSION2 carried a 5h extension of 13 bp which was complementary to the 3h end of FUSION1 (see below). A promoterless chloramphenicol O-acetyltransferase (CAT) gene (cat) was amplified from pMH109 (Hudson & Stewart, 1986 ) using primers FUSION1 (5h-TTCTATAGTAACTT-TCAAGGAGCTCGAAATCCGGAGGC-3h) and Tet\Cat (5h-GGATCCGGGCCACCTCGACC-3h ; BamHI site shown in bold type). FUSION1 carried a 5h extension of 19 bp which was complementary to the 3h end of FUSION2. PCR products of the correct size were purified, mixed and used in PCR amplification with primers PROMF and Tet\Cat. The resulting fbpA promoter-cat (p-fbpA-cat) fusion product (1n4 kb) was digested with XbaI and BamHI, and then ligated with pFW5 that had been similarly digested, to generate pFWFUSION1. Plasmid pFWFUSION1 was introduced onto the S. gordonii chromosome by transformation and selection for spectinomycin resistance, to generate strain UB1300. The insertion also conferred resistance to S. gordonii against 10 µg chloramphenicol ml − ".
Binding of recombinant FbpA to immobilized fibronectin.
Human fibronectin (Boehringer Mannheim) was applied to microtitre plate wells and additional sites were blocked with BSA, as described previously (McNab et al., 1996) . Recombinant N-terminal His ' -tagged FbpA (1n25 µg) was incubated in fibronectin-coated or BSA-coated (control) wells for 2 h at 37 mC. Wells were washed with TNMC buffer (1 mM Tris\ HCl, 150 mM NaCl, 0n1 mM MgCl # , 0n1 mM CaCl # , pH 8n0) and incubated with His & antibody (Qiagen ; 1 : 1000) for 1 h at room temperature. After rinsing the wells with TNMC, bound antibody was detected with horseradish-peroxidaseconjugated anti-mouse IgG (Dako ; 1 : 1000) and o-phenylenediamine. ELISA (A %*# ) values for protein bound to fibronectin were corrected by subtracting the background value detected for the binding of protein to the BSA-blocked (control) wells. To measure the effects of gelatin on FbpA binding to fibronectin, FbpA was added to fibronectin-coated wells that had been pre-incubated with gelatin (1 mg ml − ") for 1 h at 37 mC. Hydrophobicity, adhesion and aggregation assays. Cellsurface hydrophobicity was estimated as the percentage of total cells partitioning with hexadecane (Jenkinson, 1987) . The adhesion of S. gordonii cells to fibronectin was performed as described previously (McNab et al., 1996) . Briefly, S. gordonii cells were radiolabelled by growth in TY-glucose medium containing [methyl-$H]thymidine [6 µCi ml − " (78 Ci mmol − ", 2n89 TBq mmol − ") ; Amersham]. They were then washed thoroughly and added to microtitre plate wells that had been fibronectin-coated and BSA-blocked as before. Plates were incubated at 37 mC for 2 h with gentle shaking, and the numbers of bound cells were then determined by scintillation counting (Jenkinson et al., 1993) . The saliva-mediated agglutination of bacterial cells was determined spectrophotometrically using the method described previously by Jenkinson et al. (1993) , with the decrease in the OD '!! value being measured over time. Analysis of bacterial proteins. Bacteria from a late-exponential phase culture (30 ml) of S. gordonii DL1, OB235 cshA3 or UB1060 fbpA were harvested by centrifugation (4000 g, 10 min, 4 mC), washed once in TP buffer [50 mM Tris\HCl, pH 7n8, containing 5 % (v\v) protease inhibitor cocktail ; 5 ml] and suspended in 0n2 ml spheroplasting buffer [20 mM Tris\ HCl, pH 6n8, 10 mM MgCl # , 26% (w\v) raffinose ; Jenkinson et al., 1993] . Mutanolysin (500 U ml − " ; Sigma) and lysozyme (0n2 mg ml − ") were added, and the suspension was incubated at 37 mC for 20 min. TP buffer (0n2 ml) was then added to the suspension, and the cells were disrupted by sonication (4i15 s at 280 W cm − #, with cooling on ice between each pulse) using an Ikasonic U50 hand-held sonicator fitted with a 3-mmdiameter probe (IKA-Werke GMBH, Staufen, Germany). The suspension was fractionated by centrifugation (12 000 g, 10 min, 4 mC) and the supernatant (soluble fraction) was carefully removed. The cell-envelope pellet was washed twice by suspension and centrifugation in TP buffer, and the proteins were solubilized from the fractions with 1 % (w\v) SDS (final concentration) by heating for 10 min at 90 mC. The solutions were then mixed with loading dye (Jenkinson et al., 1993) . Proteins were separated by SDS-PAGE on 8 % (w\v) acrylamide gels and then transferred to Hybond-C nitrocellulose membranes (Amersham) by electroblotting (McNab & Jenkinson, 1992) . Antibodies against FbpA were affinity-purified by incubating FbpA antiserum with a nitrocellulose strip containing recombinant FbpA. Bound antibodies were eluted with 0n2 M glycine\HCl, pH 2n5, as described previously (Jenkinson & Easingwood, 1990) . Antibody binding on immunoblots was detected by using peroxidase-conjugated swine immunoglobulins to rabbit IgG and enhanced chemiluminescence (ECL ; Amersham), according to manufacturer's instructions.
The immunoreactivity of CshA on intact cells was determined by ELISA, as described previously (Holmes et al., 1996) , using antibodies raised against a recombinant fragment of the CshA polypeptide comprising the N-terminal 844 aa residues of the mature CshA polypeptide (N-CshA ; McNab et al., 1996) .
Preparation of cell-free extracts and CAT assay. Cell-free extracts were prepared and assayed for CAT activities as described previously (McNab & Jenkinson, 1998) . Briefly, streptococcal cells in BHY medium (10 ml) were harvested by centrifugation (4000 g, 10 min, 4 mC) and washed once in TPE buffer (100 mM Tris\HCl, pH 7n8, containing 1 mM PMSF and 1 mM EDTA). The bacteria were then resuspended in spheroplasting buffer. Mutanolysin (final concentration 500 U ml − ") was added and the suspension was incubated for 30 min at 37 mC. Cells were disrupted by vortexing with glass beads. The suspensions were then centrifuged (12 000 g, 20 min, 4 mC) to remove the glass beads and cell debris ; the supernatants were removed for enzyme assays. Protein concentrations were determined by using a Bio-Rad protein assay kit, with bovine γ-globulin as the standard. CAT activity was determined by the spectrophotometric method of Shaw (1975) , utilizing a Shimadzu UV-1201 recording spectrophotometer. The reaction rate was determined from the linear portion of the graph and corrected for the background change in A %"# . The corrected value was divided by 0n0136 to yield CAT activity expressed as nmol chloramphenicol acetylated min − " (mg protein) − " at 37 mC.
RESULTS
Sequence of the fbpA gene
The cshA gene of S. gordonii DL1-Challis encodes a 259 kDa wall-anchored fibronectin adhesin (McNab et al., 1996) . Analysis of sequence data immediately 3h to cshA, generated during sequencing of the cshA chromosomal locus, revealed the presence of a partial ORF with sequence similarity to FBP54, a fibronectin-and fibrinogen-binding protein of S. pyogenes (Courtney et al., 1994 (Courtney et al., , 1996 . To investigate the role of this gene in fibronectin binding, we amplified, by inverse PCR, a 3n63 kb fragment that overlapped with the previously reported cshA sequence. Computer analysis of 2049 bp of sequence downstream of the cshA stop codon (GenBank accession no. X65164, updated to include downstream sequence) revealed a complete ORF, designated FbpA (fibronectin-binding protein A), of 550 aa residues (62 693 Da). FbpA demonstrated 81 % identity to the FBP54 sequence (550 aa residues) deduced from the S. pyogenes M1 complete genome sequence (GenBank accession no. AAK33911 ; Ferretti et al., 2001) and 85 % sequence identity to S. pneumoniae PavA (Holmes et al., 2001) . The FBP54 polypeptide, as initially discovered by Courtney et al. (1994) , was missing 76 aa residues from the N terminus.
S. gordonii
FbpA was encoded on the opposite strand to CshA, with the cshA and fbpA stop codons separated by 75 bp (Fig. 1a) . Within this region was a single potential stem-loop structure previously identified as a ρ-independent transcriptional terminator for cshA (overscored in Fig. 1a) . At the 5h end of fbpA there was a potential ribosome-binding site (RBS) (GGAGA) and an extended k10 promoter sequence (underscored in Fig. 1b) , comprising a k16 region (TTTG ; Voskuil & Chambliss, 1998) upstream of a canonical k10 region (TATAAT), positioned appropriately to the fbpA start codon (Fig. 1b) . No recognizable k35 sequence was present in the promoter region of fbpA. However, the extended k10 sequence can function naturally in the absence of a k35 site (Sabelnikov et al., 1995) , and it was predicted that fbpA was expressed from its own promoter. The deduced amino acid sequence of FbpA contained no conventional N-terminal hydrophobic leader or signal peptidase cleavage site to direct export via the general secretory pathway. Also, there was no Gram-positive bacterial cell-wall anchorage motif (LPXTG, where X is any amino acid ; Navarre & Schneewind, 1999) at the C-terminal end of FbpA. The sequence was relatively leucine rich (61 residues out of 550), a feature previously noted for FBP54 of S. pyogenes (Courtney et al., 1994) .
To detect the expression of FbpA by streptococcal cells, we utilized affinity-purified antibodies raised against recombinant FbpA (see Methods). A major polypeptide band with an approximate molecular mass of 60 kDa was detected on immunoblots of proteins from envelope (containing membrane and wall-associated proteins) and soluble (cytoplasmic) fractions of S. gordonii DL1-Challis cells (Fig. 2, lanes 1 and 2) .
Role of FbpA in S. gordonii adhesion to fibronectin
Adhesion of S. gordonii cells to immobilized human fibronectin has been shown to be mediated by CshA (McNab et al., 1996) . However, since cshA mutants of S. gordonii are only approximately 50 % reduced in their binding to fibronectin, at least one other adhesin might be involved (McNab et al., 1996) . To determine if this additional adhesin was FbpA, the fbpA gene was inactivated as described in Methods. A representative tetracycline-resistant mutant of DL1-Challis, designated UB1060, was isolated and characterized in further studies. Insertion of the antibiotic-resistance determinant at the fbpA locus was confirmed by Southern analysis (data not shown). The FbpA protein was absent in immunoblots of envelope and soluble-protein fractions prepared from mutant strain UB1060 (Fig. 2, lanes  3 and 4) . Insertional inactivation of the adjacent cshA gene (strain OB235) did not affect expression of FbpA (Fig. 2, lanes 5 and 6) . The growth rates of the mutant strain UB1060 fbpA ::tet were similar to those of the wild-type strain at 37 and 42 mC (data not shown).
The ability of wild-type and UB1060 fbpA cells to adhere to immobilized human fibronectin was measured using a microtitre-plate-based assay (see Methods). The adhesion of mid-exponential phase cells of UB1060 to fibronectin was reduced by approximately 25 %, when compared with wild-type cells harvested at the same phase of growth (Table 2) . However, stationary phase cells of UB1060 and DL1-Challis adhered to fibronectin to approximately the same extent as each other ( Table 2 ). The binding of wild-type or UB1060 cells to fibronectin was inhibited by gelatin to a similar degree (45n2%p3n0 %) (data not shown). The adhesion of S. gordonii OB235 cshA3 cells to fibronectin was reduced by approximately 45 %, irrespective of whether the cells were harvested in the exponential or stationary phases of growth (Table 2) . Inactivation of fbpA also resulted in significantly reduced surface hydrophobicity of UB1060 cells harvested in the mid-exponential phase of growth, but this reduction was not seen in cells harvested during the stationary phase of growth ( Table  2 ). The hydrophobicity of OB235 (cshA3) was greatly reduced irrespective of the growth phase ; this was in accordance with previous results correlating CshA with surface hydrophobicity (McNab & Jenkinson, 1992) . Saliva-mediated aggregation of exponential or stationary phase cells was unaffected in UB1060, when compared with the wild-type (data not shown).
To determine if FbpA bound to human fibronectin, fbpA was cloned into pQE30 and the His ' -tagged recombinant protein was expressed in E. coli following IPTG induction. Recombinant FbpA was purified using Ni-NTA affinity chromatography, and it was isolated as a single band by SDS-PAGE (data not shown). Recombinant FbpA bound avidly to immobilized human fibronectin (Fig. 3) , but showed no binding to BSA. Conversely, we were unable to detect binding of soluble fibronectin to purified FbpA that had been immobilized on nitrocellulose membranes or in plastic wells (data not shown).
Inactivation of fbpA affects cshA gene expression
Although recombinant FbpA was shown to bind fibronectin, the effects of fbpA gene inactivation on cellsurface hydrophobicity and adhesion to fibronectin suggested that the expression of CshA might be affected. This was first investigated by ELISA using CshA-reactive antibodies (McNab et al., 1996) . Mid-exponential phase 
Fig. 4. Specific CAT activity in cells of S. gordonii strain OB507
(p-cshA-cat) (#), strain UB1245 (p-cshA-cat fbpA) ($) and strain UB1300 (p-fbpA-cat) (=) at points during their growth in batch culture ( ; culture density at OD 600 for strain OB507). The results presented (meanpSD for triplicate samples) are from a representative experiment of four repeats. Strains OB507 and UB1245 had similar growth curves.
cells of mutant strain UB1060 fbpA showed a 35 % decrease in their surface presentation of CshA when compared with wild-type cells (Table 2) , whereas stationary phase cells showed no difference in their surface presentation of this protein. To investigate this further, the fbpA gene was inactivated in a cshA promoter-cat (p-cshA-cat) reporter strain (OB507 ; McNab & Jenkinson, 1998) to generate UB1245. Cell-free extracts of OB507 (p-cshA-cat) or UB1245 (p-cshA-cat fbpA) were prepared from batch-culture samples taken at intervals during growth. CAT-specific activities in cell-free extracts of OB507 were found to increase throughout growth and reached a maximum in the early-stationary phase (Fig. 4) , confirming previous results (McNab & Jenkinson, 1998) . By contrast, CATspecific activities were significantly lower in cell-free extracts of strain UB1245 cells in the early-and midexponential phases of growth. However, by the time UB1245 cultures entered the early-stationary phase their CAT-specific activities approached those of OB507 (Fig. 4) . These data suggested that the inactivation of fbpA affected cshA promoter activity during the exponential phase of growth, thus accounting for the reduced surface presentation of CshA on these cells (Table 2 ).
Construction and characterization of the fbpA promoter-cat fusion
To investigate the expression levels of fbpA at various stages during batch-culture growth, a fbpA promotercat fusion strain, UB1300, was generated (see Methods). In this construct, the RBS sequence for fbpA (GGAGA) was replaced with the cat RBS sequence (GGAGG), and the RBS-ATG spacing was increased from five nucleotides to eight nucleotides (Fig. 1b) , identical to the p-cshA-cat construct (McNab & Jenkinson, 1998) .
By contrast to cshA expression, which increases in the late-exponential phase of growth, fbpA promoter activity remained at a relatively constant level throughout growth and into the stationary phase (Fig. 4) . However, fbpA promoter activity was consistently lower (five-to eightfold) than that of the cshA promoter. An fbpA mRNA transcript of approximately 1850 nt was visualized in Northern-blot analysis of RNA isolated from cells of S. gordonii DL1. In support of the CAT reporter data, the levels of fbpA mRNA with respect to total RNA did not alter significantly throughout growth and into the stationary phase (Fig. 5) . Okada et al., 1993 ; VanHeyningen et al., 1993 ; McLandsborough & Cleary, 1995) , we determined whether environmental O # levels affected cshA or fbpA transcription. The activity of the cshA promoter was apparently unaffected by cultivation of cells in static broth, under reduced O # (anaerobic cabinet) or under aeration (Table 3) . By contrast, in the p-fbpA-cat fusion strain, the specific CAT activity was elevated nearly threefold in aerated cultures compared with the activity seen in anaerobic cultures (Table 3) .
DISCUSSION
Fibronectin binding by bacteria is an important property that may promote colonization of the host and contribute to disease progression. The list of fibronectinbinding proteins expressed by streptococci is increasing, and at least eight different fibronectin-binding proteins have now been identified in group A streptococci alone (Joh et al., 1999 ; Terao et al., 2001) . In this study, we have identified FbpA as a second fibronectin-binding protein in oral S. gordonii. The fbpA gene lies immediately downstream of the cshA gene that encodes a major fibronectin-binding protein of S. gordonii (McNab et al., 1994 (McNab et al., , 1996 .
FbpA of S. gordonii exhibits several features that distinguish it from the other fibronectin-binding proteins of Gram-positive bacteria that have been characterized to date. FbpA does not contain sequences that closely match recognized motifs involved in binding fibronectin, suggesting that binding may be mediated by a novel mechanism. In support of this, streptococcal and staphylococcal proteins that contain consensus fibronectinbinding motifs are able to bind soluble and immobilized fibronectin, generally interacting with the N-terminal fibrin-and heparin-binding domain of fibronectin (Joh et al., 1999) . Like CshA, FbpA binds to only the immobilized form of fibronectin and, since these two proteins show no amino acid similarity, their mechanisms of fibronectin binding may be different or may involve protein configurations that are not easily defined through linear sequence motifs.
The inactivation of fbpA was associated with a significant reduction in the fibronectin binding and cell-surface hydrophobicity of S. gordonii cells harvested at the exponential phase of growth. However, our results suggest that these phenotypic effects resulted from a reduction in the expression of CshA. Although we cannot rule out that, under some growth conditions, FbpA may mediate adhesion of S. gordonii to fibronectin, it would appear that the CshA-independent mechanism of binding of stationary phase cells is not due to FbpA. In support of this, we have not been able to conclusively demonstrate cell-surface localization of FbpA by immunogold electron microscopy using affinity-purified FbpA antibodies (data not shown). By contrast, the orthologous PavA protein of S. pneumoniae, which partly mediates pneumococcal cell adhesion to fibronectin (Holmes et al., 2001) , has been shown to be cell-surface exposed. PavA and FbpA both appear to partition between the soluble (cytoplasmic) and envelope (containing membrane and wall-associated proteins) fractions of cells. Neither of these proteins carries conventional secretory (signal peptide) nor cell-surface anchorage sequences, so the mechanism by which PavA is secreted and becomes cell-surface-associated is currently unknown.
The ability of bacteria to sense and respond to environmental influences is integral to their survival and adaptation within the host (Finlay & Falkow, 1997) . The level of O # varies at host sites and bacteria respond to this. Fibronectin-binding protein PrtF1 of S. pyogenes is maximally expressed under aerobic conditions ( VanHeyningen et al., 1993) , and this is thought to enhance colonization at superficial body sites. We have also shown that O # levels may directly regulate the expression of FbpA, but that this does not significantly impact on CshA production. The cshA promoter is apparently under complex regulatory control, since it has been demonstrated that maximal cshA promoter IP: 54.70.40.11
On: Sat, 06 Jul 2019 10:48:05 S. gordonii fibronectin-binding protein FbpA activity in the early-stationary phase of growth requires a functional Hpp oligopeptide transport system (McNab & Jenkinson, 1998) as well as the co-production of CshB (McNab & Jenkinson, 2000) . HppA, which is an oligopeptide-binding protein , is thought to be involved in sensing an extracellular signal that modulates the expression of cshA in a cell-densitydependent manner. The data presented here suggest that FbpA provides another layer of control on CshA expression during the exponential phase of growth. It is unclear how this operates at present, and we have been unable to show by gel-shift assay that purified FbpA binds to the cshA promoter (data not shown). It is possible that FbpA may act as an accessory factor involved in HppA-dependent peptide signal detection, or as an independent regulator which would allow the integration of multiple sensory signals at the level of adhesin gene transcription. In S. pyogenes, Mga positively regulates the expression of several virulence factors, including SOF and Fba, at the transcriptional level (McLandsborough & Cleary, 1995 ; Terao et al., 2001) . The expression and activity of Mga is, in turn, affected by various environmental stimuli (Okada et al., 1993 ; Podbielski et al., 1992) , and an additional level of control occurs through Nra, a negative regulator of Mga transcription whose expression is cell-density-dependent (Podbielski et al., 1999) . Nra also directly regulates the expression of the fibronectin-binding protein PrtF2 (Podbielski et al., 1999) . PrtF, another fibronectinbinding protein of group A streptococci, is positively regulated by the transcriptional factor RofA, whose expression is elevated under anaerobic conditions (Fogg et al., 1994 (Fogg et al., , 1997 . These multiple layers of regulation controlling the expression of fibronectin-binding proteins in streptococci highlight the importance of detecting and integrating spatial and temporal information for colonization and survival within the host.
Orthologues of FbpA are present in a wide range of streptococci, in Lactococcus lactis, in Bacillus subtilis and in some Gram-negative species of bacteria. The PavA protein of S. pneumoniae is essential for pneumococcal virulence (Holmes et al., 2001 ; Lau et al., 2001) , while a promoter trap screening system has demonstrated that an FbpA-like protein in Streptococcus suis is expressed during experimental infection of piglets (Smith et al., 2001) . It has also been shown that mice immunized with recombinant FBP54 were protected against S. pyogenes infection . Thus, while the role of these FbpA-like proteins in streptococcal infections are not yet understood, they are important for bacterial growth and survival within the host and they may provide novel targets for disease intervention.
